Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Know This Trade Level For This Leading Bio-Tech Stock

|Includes: Biogen Inc. (BIIB)

One of the leading biotechnology stocks that has been under pressure recently is Biogen Inc (NASDAQ:BIIB). This stock has been selling off since the company reported earnings on April 25th, 2017. On that day, BIIB stock traded as high as $291.90 a share. Since that time, the bio-tech giant has dropped lower by nearly $34.00. Currently, BIIB stock is trading at $258.86 a share.

Traders and investors should note that the charts are signaling institutional support around the $250.00 area. This is a solid whole round number that the institutional traders and investors usually like to play. It is also a level where the stock was defended in the past. Traders should note that this trade level was chart support in late January 2017 and late October 2016. Very often, past support levels will be solid levels for bounces when retested.

Nicholas Santiago

InTheMoneyStocks